Impact
Vulnerability disclosed in the eDetailing component of Oracle Siebel Apps – Life Sciences allows an unauthenticated attacker with HTTP network access to compromise the application. The flaw corresponds to CWE‑284: Improper Authorization and has a CVSS v3.1 base score of 8.1. Successful exploitation requires a user other than the attacker to interact with the system, after which the attacker can create, delete, modify, or otherwise alter critical data. The impact includes loss of confidentiality and integrity of all Siebel Apps – Life Sciences accessible data.
Affected Systems
Oracle Corporation Siebel Apps – Life Sciences versions 17.0 through 26.7 are affected. No other products are listed as impacted by this vulnerability.
Risk and Exploitability
The vulnerability carries a CVSS v3.1 base score of 8.1, indicating high severity with substantial confidentiality and integrity impact. Its EPSS score is below 1%, suggesting very low likelihood of exploitation at present, and it is not listed in CISA’s KEV catalog. However, since the attack vector is unauthenticated HTTP traffic and requires a legitimate user to trigger the flaw, the risk remains significant for organizations that deploy the Siebel Apps – Life Sciences eDetailing component. The vulnerability corresponds to CWE‑284, meaning that improper authorization controls enable unauthorized access to sensitive data.
OpenCVE Enrichment